Tevard Biosciences announces collaboration with Vertex to develop novel tRNA-based therapies for Duchenne muscular dystrophy ...Middle East

PR Newswire - News
Tevard Biosciences announces collaboration with Vertex to develop novel tRNA-based therapies for Duchenne muscular dystrophy
CAMBRIDGE, Mass., Feb. 28, 2023 /PRNewswire/ -- Tevard Biosciences, Inc., the pioneer of tRNA-based therapies for severe genetic diseases, today announced a four-year global research collaboration with Vertex Pharmaceuticals Incorporated aimed at creating new tRNA-based therapies for...

Hence then, the article about tevard biosciences announces collaboration with vertex to develop novel trna based therapies for duchenne muscular dystrophy was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Tevard Biosciences announces collaboration with Vertex to develop novel tRNA-based therapies for Duchenne muscular dystrophy )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News
myMOTHERLODE - before 6 hours & 45 minute